Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328025000172 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849763568977707008 |
|---|---|
| author | Katie Erdos Aya Alshareef Richard T. Silver Joseph M. Scandura Ghaith Abu-Zeinah |
| author_facet | Katie Erdos Aya Alshareef Richard T. Silver Joseph M. Scandura Ghaith Abu-Zeinah |
| author_sort | Katie Erdos |
| collection | DOAJ |
| format | Article |
| id | doaj-art-52e5c70cdb5e4fd282adce20af818a79 |
| institution | DOAJ |
| issn | 2950-3280 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Neoplasia |
| spelling | doaj-art-52e5c70cdb5e4fd282adce20af818a792025-08-20T03:05:22ZengElsevierBlood Neoplasia2950-32802025-05-012210008210.1016/j.bneo.2025.100082Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosisKatie Erdos0Aya Alshareef1Richard T. Silver2Joseph M. Scandura3Ghaith Abu-Zeinah4Richard T. Silver, M.D. Myeloproliferative Neoplasm Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NYWeill Cornell Medicine-Qatar, Doha, QatarRichard T. Silver, M.D. Myeloproliferative Neoplasm Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NYRichard T. Silver, M.D. Myeloproliferative Neoplasm Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NYRichard T. Silver, M.D. Myeloproliferative Neoplasm Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY; Correspondence: Ghaith Abu-Zeinah, Division of Hematology and Medical Oncology, Weill Cornell Medicine, 1300 York Ave, Box 113, New York, NY 10065;http://www.sciencedirect.com/science/article/pii/S2950328025000172 |
| spellingShingle | Katie Erdos Aya Alshareef Richard T. Silver Joseph M. Scandura Ghaith Abu-Zeinah Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis Blood Neoplasia |
| title | Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis |
| title_full | Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis |
| title_fullStr | Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis |
| title_full_unstemmed | Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis |
| title_short | Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis |
| title_sort | outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis |
| url | http://www.sciencedirect.com/science/article/pii/S2950328025000172 |
| work_keys_str_mv | AT katieerdos outcomesforruxolitinibonlyversuscombinationwithinterferonintreatingpatientswithmyelofibrosis AT ayaalshareef outcomesforruxolitinibonlyversuscombinationwithinterferonintreatingpatientswithmyelofibrosis AT richardtsilver outcomesforruxolitinibonlyversuscombinationwithinterferonintreatingpatientswithmyelofibrosis AT josephmscandura outcomesforruxolitinibonlyversuscombinationwithinterferonintreatingpatientswithmyelofibrosis AT ghaithabuzeinah outcomesforruxolitinibonlyversuscombinationwithinterferonintreatingpatientswithmyelofibrosis |